OPSYNVI
Actelion Pharmaceuticals Ltd
Mark For: OPSYNVI™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90165717 |
| Mark Literal Elements | OPSYNVI |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2021-04-20 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Cheryl Foytlin |
| Attorney Docket Number | T41887US2 |
Timeline
| 2020-09-08 | Application Filed |
| 2020-09-11 | Location: NEW APPLICATION PROCESSING |
| 2020-09-11 | Status: Live/Pending |
| 2020-09-11 | Transaction Date |
| 2021-02-23 | Published |
| 2021-04-20 | Location: INTENT TO USE SECTION |
| 2022-10-19 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Actelion Pharmaceuticals Ltd |
| Address | Gewerbestrasse 16 Allschwil SWITZERLAND CH-4123 |
| Legal Entity Type | Société Anonyme (sa) |
| Legal Entity State | SWITZERLAND |
Documents
 Application | 2020-09-08 | |
| Drawing | 2020-09-08 | |
| Notation to File | 2021-01-14 | |
| XSearch Search Summary | 2021-01-14 | |
| TRAM Snapshot of App at Pub for Oppostn | 2021-01-15 | |
| Notice of Publication | 2021-02-03 | |
| Notification Of Notice of Publication | 2021-02-03 | |
| OG Publication Confirmation | 2021-02-23 | |
| Notice of Allowance | 2021-04-20 | |
| Extension of Time to File SOU | 2021-07-06 | |
| ITU Extension Approval | 2021-07-08 | |
| ITU Unit Action | 2021-07-08 | |
| Extension of Time to File SOU | 2022-04-07 | |
| ITU Extension Approval | 2022-04-09 | |
| ITU Unit Action | 2022-04-09 | |
| Extension of Time to File SOU | 2022-10-19 | |
| ITU Extension Approval | 2022-10-21 | |
| ITU Unit Action | 2022-10-21 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives |
| GS0051 | Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of digital ulcers; pharmaceutical preparations for the treatment of glycolipid storage diseases; pharmaceutical preparations for the treatment of cerebrovascular diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical anti-allergic preparations and substances; anti-infectives |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-10-21 | |
| TEAS EXTENSION RECEIVED | 2022-10-19 | |
| SOU EXTENSION 3 GRANTED | 2022-10-19 | 98765 |
| SOU EXTENSION 3 FILED | 2022-10-19 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-04-09 | |
| TEAS EXTENSION RECEIVED | 2022-04-07 | |
| SOU EXTENSION 2 GRANTED | 2022-04-07 | 98765 |
| SOU EXTENSION 2 FILED | 2022-04-07 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-07-08 | |
| TEAS EXTENSION RECEIVED | 2021-07-06 | |
| SOU EXTENSION 1 GRANTED | 2021-07-06 | 98765 |
| SOU EXTENSION 1 FILED | 2021-07-06 | 98765 |
| EXTENSION 1 GRANTED | 2021-07-06 | 98765 |
| EXTENSION 1 FILED | 2021-07-06 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-04-20 | |
| PUBLISHED FOR OPPOSITION | 2021-02-23 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-02-23 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-02-03 | |
| ASSIGNED TO EXAMINER | 2021-01-14 | 76733 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-01-14 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-10-14 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-09-11 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OPSYNVI 98039863 not registered Live/Pending |
Actelion Pharmaceuticals Ltd 2023-06-13 |
 OPSYNVI 90165717 not registered Live/Pending |
Actelion Pharmaceuticals Ltd 2020-09-08 |
 OPSYNVI 87331161 not registered Live/Pending |
Actelion Pharmaceuticals Ltd 2017-02-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 